awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35117568-4D27BF29-45C9-4972-99CF-86587740C7D1
Q35117568-4D27BF29-45C9-4972-99CF-86587740C7D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35117568-4D27BF29-45C9-4972-99CF-86587740C7D1
From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.
P2860
Q35117568-4D27BF29-45C9-4972-99CF-86587740C7D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35117568-4D27BF29-45C9-4972-99CF-86587740C7D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
762930c89fe262e1ced4f26817c5b6d1f0bddf22
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.